This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wolfhagen, M J Articles by Verhoef, J Search for Related Content PubMed PubMed Citation Articles by Wolfhagen, M J Articles by Verhoef, J

Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay.

Eijkman-Winkler Laboratory for Medical Microbiology, University Hospital Utrecht, The Netherlands.

ABSTRACT

Rapid detection of toxigenic Clostridium difficile in fecal samples was accomplished with the magnetic immuno PCR assay (MIPA). Elaborate DNA extraction techniques were unnecessary. First, we generated a mouse monoclonal antibody (MAb) reactive with only C. difficile, Clostridium sordellii, and Clostridium bifermentans. Then, magnetic beads were coated with the MAb, incubated with fecal samples to allow binding with C. difficile, extracted from the stool with a magnet, and processed in the PCR with primers specific for the toxin B gene. After optimizing MIPA by raising the number of PCR cycles from 35 to 40 and adding Chelex 100 to the PCR mixture, we found a sensitivity of 96.7%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 94.1% when compared with the culture of cytotoxic C. difficile from fecal samples. MIPA is a rapid, easy, and sensitive PCR method for demonstrating the presence of toxigenic C. difficile in stool samples and avoids the disadvantage of elaborate extraction of DNA from fecal samples.

This article has been cited by other articles:

• Pelaez, T., Alcala, L., Alonso, R., Martin-Lopez, A., Garcia-Arias, V., Marin, M., Bouza, E. (2005). In Vitro Activity of Ramoplanin against Clostridium difficile, Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to Metronidazole. Antimicrob. Agents Chemother. 49: 1157-1159 [Abstract] [Full Text]  
• Alonso, R, Martin, A, Pelaez, T, Marin, M, Rodriguez-Creixems, M, Bouza, E (2005). Toxigenic status of Clostridium difficile in a large Spanish teaching hospital. J Med Microbiol 54: 159-162 [Abstract] [Full Text]  
• Belanger, S. D., Boissinot, M., Clairoux, N., Picard, Francois. J., Bergeron, M. G. (2003). Rapid Detection of Clostridium difficile in Feces by Real-Time PCR. J. Clin. Microbiol. 41: 730-734 [Abstract] [Full Text]